20Jan 2017

BASELINE RENAL DYSFUNCTION IN ACUTE ISCHEMIC STROKE PATIENTS: PREVALENCE AND IMPACT ON EARLY MORTALITY.

  • Department of Internal Medicine, Zagazig University; Egypt. Department of Neurology, Zagazig University; Egypt.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Introduction: Stroke is considered the second leading cause of death globally. Chronic kidney disease (CKD) has been identified as a risk factor for stroke. However, little is known about the impact of renal dysfunction on early mortality following acute ischemic stroke. The aim of the current study was to evaluate the prevalence of renal dysfunction among acute ischemic stroke patients and its role on the early overall mortality. Patients and methods: This prospective cohort study included a total of 889 patients with first ever ischemic stroke who were hospitalized within 24 hours of symptoms onset. All patients were clinically evaluated to determine stroke risk factors. Stroke severity was assessed using National Institute of Health Stroke Scale (NIHSS) in the 1st day of admission. Baseline investigations were obtained within 24 hours of admission, including serum creatinine and estimated Glomerular Filtration Rate (eGFR) that was calculated from the equation of the Modification Diet for Renal Disease in ml/min/1.73m2. Patients were followed up for 30 days after admission or at least until death. Results: Of the 800 stroke patients who completed follow up during the study period, 242 (30.2%) had renal dysfunction, and 128 (16%) died within 30-days of stroke onset, whereas mortality was higher (19.8%) in patients with eGFR <60 ml/min/1.73m2 than in patients (14%) with eGFR ?60 ml/min/1.73m2. In multivariate analysis, 30–days mortality risk of stroke was higher in patients with eGFR< 60ml/min/1.73 m2 (HR= 1.7, 95% CI=1.4–2, P=0.002), stroke severity (HR= 1.5, 95% CI=1.3- 1.7, P=0.001), and presence of atrial fibrillation (HR= 1.4, 95% CI=1.1-1.7, P=0.007). Meanwhile, the odds of mortality risk increased by 1.7 for each 1 mg/dl increase in baseline serum creatinine. Conclusion: The prevalence of renal dysfunction in our cohort of acute ischemic stroke patients was high. Presence of baseline renal dysfunction was recorded as an independent predictor of early mortality in the setting of acute ischemic stroke beside other well-known prognostic factors.


  1. Lozano R ,Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for  20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095–128
  2. Heuschmann PU, Kolominsky-Rabas PL, Roether J, et al. Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy. JAMA. 2004: 292(15):1831-8.
  3. Hojs R and Fabjan T H. Renal Dysfunction and Ischemic Stroke. ACTA FACULTATIS MEDICAE NAISSENSIS 2013; 30(4): 185-191.
  4. Masson P , Webster A C ,  Hong M et al. Chronic kidney disease and the risk of stroke: a systematic review and meta-analysis. Nephrol Dial Transplant 2015;  30: 1162–1169.
  5. El-Menyar A, Zubaid M, Sulaiman K, et al. In-hospital major clinical outcomes in patients with chronic renal insufficiency presenting with acute coronary syndrome: data from a Registry of 8176 patients. Mayo ClinProc 2010; 85(4): 332–40.
  6. Ovbiagele B, SanossianN, Liebeskind DS, et al. Indices of kidney dysfunction and discharge outcomes in hospitalized stroke patients without known renal disease. Cerebrovasc Dis 2009; 28(6): 582–8
  7. Agrawal V, Rai B, Fellows J, et al. In-hospital outcomes with thrombolytic therapy in patients with renal dysfunction presenting with acute ischemic stroke. Nephrol Dial Transplant 2010; 25(4):1150–7
  8. Ovbiagele B  Chronic kidney disease and risk of death during hospitalization for stroke. Journal of the Neurological Sciences 2011; 301(1-2):   46–50.
  9. Kasner SE: Clinical interpretation and use of stroke scales. The Lancet Neurology 2006; 5(7): 603-612.
  10. Levey AS, Coresh J, Greene T, et al.  Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006 ;15 : 145(4): 247-54.
  11. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139(2):137–47.
  12. IBM Corp. Released 2010. IBM SPSS Statistics for Windows, Version 20. Armonk, NY: IBM Corp; 2010
  13. Lima HN, Cabral NL, Gonçalves AR, et al. Association between albuminuria, glomerular filtration rate and mortality or recurrence in stroke patients. Nephron ClinPract. 2011; 117:246–252.
  14. Sander D, Weimar C, Bramlage P et al. Microalbuminuria indicates long-term vascular risk in patients after acute stroke undergoing in-patient rehabilitation. BMC Neurol. 2012;12:102.
  15. Toyoda K. Cerebral small vessel disease and chronic kidney disease. J Stroke  2015; 17:31 37.
  16. Matsushita K, Coresh J, Sang Y et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2015; 3:514–525
  17. Mahmoodi BK, Yatsuya H, Matsushita K et al. Association of kidney disease measures with ischemic versus hemorrhagic strokes: pooled analyses of 4 prospective community- based cohorts. Stroke 2014; 45:1925–1931.
  18. Horio M, Imai E, Yasuda Y et al. Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis. 2010; 56:32–38.
  19. Hoshino H, Itoh Y, Yamada S, et al. Clinical features and neurologic severity in stroke patients with mild to moderate renal dysfunction. J Stroke Cerebrovasc Dis 2012; 21(5): 343-349.
  20. Tsagalis G, Akrivos T, Alevizaki M, et al (2009). Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality. Nephrol Dial Transplant 24(1): 194-200.
  21. Yahalom G, Schwartz R, Schwammenthal Y, et al. Chronic kidney disease and clinical outcome in patients with acute stroke. Stroke 2009; 40:1296-303
  22. Kawagishi T, Nishizawa Y, Konishi T et al. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int 1995; 48: 820–6.
  23. Hojs R. Carotid intima-media thickness   and plaques in hemodialysis patients.Artif Organs 2000;9:691–5.
  24. O'Rourke M F and Safar M E (). Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005; 46(1): 200-204.
  25. Preston E, Ellis MR, Kulinskaya E, et al. Association between carotid artery intima-media thickness and cardiovascular risk factors in CKD. Am J Kidney Dis 2005; 46: 856–62.
  26. Wolfe CD, Giroud M,  Kolominsky-Rabas P, et al: Variations in stroke incidence and survival in 3 areas of Europe. European Registries of Stroke  (EROS) Collaboration. Stroke 2000; 31:  2074–2079.
  27. De Jong G, van Raak L, Kessels F et al. Stroke subtype and mortality.a follow-up study in 998 patients with a first cerebral infarct.  J ClinEpidemiol 2003;  56 (3): 262-268.
  28. Hartmann A, Rundek T, Mast H et al. Mortality and causes of death after first ischemic stroke: the Northern Manhattan Stroke Study. Neurology 2001; 57(11): 2000-2005.
  29. CovicA ,   Schiller A  ,   Mardare NG , et al.  The impact of acute kidney injury on short-term survival in an Eastern European population with stroke, Nephrol. Dial. Transplant. 2008;  23 (7): 2228-2234.
  30. Collins T C, Petersen N J, Menke T J, et al. Short-term, intermediate-term, and long-term mortality in patients hospitalized for stroke. J ClinEpidemiol 2003; 56 (1): 81-87.
  31. Castillo J, Davalos A, Marrugat J et al. Timing for fever-related brain damage in acute ischemic stroke. Stroke  1998; 29(12): 2455-2460.
  32. Nedeltchev K, Renz N, Karameshev A, et al . Predictors of early mortality after acute ischemic stroke. Swiss Med Wkly 2010; 140 (17-18): 254-259.
  33. Carter A M, Catto A J, Mansfield M W, et al. Predictive variables for mortality after acute ischemic stroke. Stroke 2007; 38(6): 1873-1880.
  34. Brzosko S, Szkolka T and MysliwiecM . Kidney disease is a negative predictor of 30-day survival after acute ischemic stroke. Nephron ClinPract 2009; 112 (2): 79-85.
  35. Sarnak M J, Levey A S, Schoolwerth A C, et al . Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108 (17): 2154-2169.
  36. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007; 116: 85–97.

[Medhat I. Mahmoud, Ahmed E. Badawy, Nahed Shehta and Bothina M. Ramadan. (2017); BASELINE RENAL DYSFUNCTION IN ACUTE ISCHEMIC STROKE PATIENTS: PREVALENCE AND IMPACT ON EARLY MORTALITY. Int. J. of Adv. Res. 5 (Jan). 502-508] (ISSN 2320-5407). www.journalijar.com


Nahed Shehta
Department of Neurology, Zagazig University, Egypt.

DOI:


Article DOI: 10.21474/IJAR01/2774      
DOI URL: http://dx.doi.org/10.21474/IJAR01/2774